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Human Liver Sinusoidal Endothelial
Cells Promote Intracellular Crawling
of Lymphocytes During Recruitment:
A New Step in Migration
Daniel A. Patten,1 Garrick K. Wilson,2 Dalan Bailey,3 Robert K. Shaw,4 Sirpa Jalkanen,5 Marko Salmi,5 Antal Rot,6
Chris J. Weston,1 David H. Adams,1 and Shishir Shetty1
The recruitment of lymphocytes via the hepatic sinusoidal channels and positioning within liver tissue is a critical event in
the development and persistence of chronic inﬂammatory liver diseases. The hepatic sinusoid is a unique vascular bed lined
by hepatic sinusoidal endothelial cells (HSECs), a functionally and phenotypically distinct subpopulation of endothelial cells.
Using ﬂow-based adhesion assays to study the migration of lymphocytes across primary human HSECs, we found that lym-
phocytes enter into HSECs, conﬁrmed by electron microscopy demonstrating clear intracellular localization of lymphocytes
in vitro and by studies in human liver tissues. Stimulation by interferon-c increased intracellular localization of lymphocytes
within HSECs. Furthermore, using confocal imaging and time-lapse recordings, we demonstrated “intracellular crawling” of
lymphocytes entering into one endothelial cell from another. This required the expression of intracellular adhesion
molecule-1 and stabilin-1 and was facilitated by the junctional complexes between HSECs. Conclusion: Lymphocyte migra-
tion is facilitated by the unique structure of HSECs. Intracellular crawling may contribute to optimal lymphocyte position-
ing in liver tissue during chronic hepatitis. (HEPATOLOGY 2016; 00:000-000).
Chronic inﬂammation is a major cause of globalmorbidity and mortality, often leading to tissueﬁbrosis and organ failure, and is also a recog-
nized risk factor for carcinogenesis.(1-4) It is character-
ized by the recruitment of immune cells into organs via
their interaction with endothelial cells followed by their
positioning in strategic locations within the tissue.(5)
This is seen in nearly all adult liver diseases that are
driven by chronic inﬂammation, where leukocytes are
recruited via specialized channels known as sinusoids,
which are lined by hepatic sinusoidal endothelial cells
(HSECs).(6) This inﬂux of immune cells often leads to
lymphoid aggregates/follicles around the portal tract in
a range of liver diseases.(7)
Despite this common pathway of chronic inﬂamma-
tion, several features contribute to the liver being a
unique site for leukocyte recruitment. The extravasation
occurs within the hepatic sinusoidal channels in contrast
to the postcapillary venules as seen in most other
organs.(8,9) These channels are characterized by a low
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ﬂow environment, and the sinusoidal endothelium (i.e.,
HSECs) has a unique morphology and performs special-
ized functions including scavenging and ﬁltration.(10)
Conventional adhesion molecules, such as selectins which
mediate leukocyte rolling, are absent from this vascular
bed, and recruitment is mediated by atypical adhesion
molecules such as vascular adhesion protein-1 and the
common lymphatic endothelial and vascular endothelial
receptor-1 (CLEVER-1) also known as stabilin-1.(11,12)
The aim of this study was to perform a detailed anal-
ysis of the transendothelial pathway used by lympho-
cytes to cross human liver sinusoidal endothelium to
identify organ-speciﬁc targets of chronic inﬂammation
within the liver. We developed real-time cell imaging by
laser scanning confocal microscopy under conditions of
physiologically relevant shear stress to visualize the
migration of lymphocytes across HSECs. We visualized
lymphocyte migration into the cytoplasm of HSECs
from where the cells crossed junctional membranes to
allow them to crawl from within one HSEC into anoth-
er. We noted this process more frequently in HSECs
compared with conventional vascular endothelium and
found it was enhanced by interferon-c (IFNc) treatment
of the endothelium. Although crawling of leukocytes on
the luminal surface has been described previously,(13) we
believe this is the ﬁrst description of “intracellular
crawling,” which may play an important role in leuko-
cyte recruitment and positioning within the liver.
Materials and Methods
HUMAN TISSUE
Human tissue and blood samples were collected
from patients admitted to the University Hospitals
Birmingham National Health Service Foundation
Trust. Liver tissue was taken from organ donors that
was surplus for surgical requirements or from unin-
volved liver removed at hepatic resection for secondary
liver tumors; diseased tissue was obtained from
patients undergoing liver transplantation for chronic
liver disease. Tissue samples from patients were
obtained with written informed consent and with local
ethics committee approval (reference numbers 06/
Q2702/61 and 04/Q2708/41, South Birmingham,
Birmingham, UK).
ENDOTHELIAL CELL
ISOLATION
HSECs were isolated from approximately 30 g
human liver tissue as described previously.(14) Brieﬂy,
tissue was subjected to collagenase digestion (10 mg/
mL collagenase IA; Sigma-Aldrich, Gillingham, Dor-
set, UK) and was placed on a 33%/77% Percoll (Amer-
sham Biosciences, Little Chalfont, Buckinghamsire,
UK) density gradient. The nonparenchymal cell layer
was then removed, and the endothelial cells were iso-
lated by positive immunomagnetic selection utilizing
CD31 antibody-conjugated Dynabeads (Thermo Fish-
er, Bishop Meadow Road, Loughborough, UK). The
endothelial cells were then cultured in medium com-
posed of human endothelial basal growth medium
(Thermo Fisher) supplemented with 10% human
serum (HD Supplies, Botolph Claydon, Buckingham-
shire, UK), 10 ng/mL vascular endothelial growth fac-
tor (PeproTech, London, UK), and 10 ng/mL
hepatocyte growth factor (PeproTech). The cells were
grown in rat tail culture vessels coated with collagen (1
in 100; Sigma-Aldrich) and were maintained at 378C
in a humidiﬁed incubator with 5% CO2. Human
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umbilical vein endothelial cells (HUVECs) isolated
using standard methods(14) were used as a control
endothelial cell line.
FLOW-BASED ADHESION ASSAY
To study lymphocyte migration in the adhesion cas-
cade within the hepatic sinusoids, cytokine-stimulated
HSECs (tumor necrosis factor a [TNFa] and IFNc
for 24 hours at 10 ng/mL) were grown to conﬂuence
in l-slide VI chambers (ibidi, Thistle Scientiﬁc,
Uddingston, Glasgow, UK) and connected to the ﬂow
system described previously.(15) In some experiments,
IFNc stimulation was performed for shorter periods (2
and 4 hours). For live cell imaging of lymphocyte
migration we used a slightly modiﬁed ﬂow-assay pro-
tocol to that used previously. Cytokine-stimulated
HSECs or HUVECs were seeded into l-slide I cham-
bers (ibidi) and were prelabeled with CellTracker
Green CMFDA (Thermo Fisher). The chambers were
then connected to an ibidi pump, which allowed con-
tinuous perfusion of lymphocytes at a shear stress of
0.05Pa. Flow assays were performed with lymphocytes
prelabeled with CellTracker Violet BMQC (Thermo
Fisher) according to the manufacturer’s guidelines. In
some assays, the endothelial cells were labeled with a
Cell Mask plasma membrane stain according to the
manufacturer’s guidelines. Some ﬂow assays were per-
formed with nonviable lymphocytes (cells underwent
ﬁxation with 4% paraformaldehyde). The endothelial
monolayers and adherent lymphocytes were visualized
and examined using a Zeiss 780 Zen microscope
equipped with a 63 3 1.32 objective. Time-lapsed
confocal images and z-stacks were acquired and ana-
lyzed using Zen software.
STATISTICAL ANALYSIS
All data are expressed as the mean 6 SEM for the
speciﬁed number of experimental repeats (n). For sin-
gle comparisons, statistical signiﬁcance was determined
using an unpaired t test, whereas evaluation of multiple
treatments was performed using analysis of variance
with a Tukey’s post hoc multiple comparison test. A P
value of  0.05 was considered statistically signiﬁcant.
All statistical analyses were performed using Prism 6
software (GraphPad Software Inc.) group.
Further details are provided in the Supporting
Information.
Results
INTRAENDOTHELIAL
LYMPHOCYTES IN CHRONIC
INFLAMMATORY LIVER DISEASE
Many chronic liver conditions are characterized by a
portal lymphocyte inﬁltrate in close relation to the site
of hepatic scar formation (Fig. 1A). Lymphocyte
recruitment is initiated within the hepatic sinusoids,(8)
which are lined by specialized endothelia characterized
by a unique phenotypic expression, including liver/
lymph node–speciﬁc intercellular adhesion molecule-
3-grabbing integrin and the scavenger receptor
stabilin-1 (Fig. 1B).(16) Using ﬂow adhesion assays
with primary HSECs, we recently reported that a pro-
portion of lymphocytes use a transcellular route to cross
sinusoidal endothelium.(12) To assess in human tissue,
sections of livers from patients with chronic liver dis-
ease were visualized by confocal microscopy and
immunoﬂuorescent labeling. We used stabilin-1 as a
marker of sinusoidal endothelial cells and CD45 and
CD3 to deﬁne lymphocytes, which allowed us to iden-
tify lymphocytes within the hepatic sinusoids and cap-
ture their interactions with lining endothelial cells
(Supporting Fig. S1A,C). We visualized lymphocytes
within the hepatic sinusoids and adherent to the endo-
thelium; in addition, we identiﬁed lymphocytes that
appeared to have migrated into the endothelial cyto-
plasm (Fig. 1C). Multilayer imaging of these CD31
cells allowed three-dimensional reconstruction to con-
ﬁrm that these cells were within sinusoidal endothelial
cells (Fig. 1D-F). We ruled out phagocytosis of lym-
phocytes by tissue resident macrophages by using the
Kupffer cell marker CD68 to distinguish Kupffer cells
from stabilin-1–positive endothelial cells (Supporting
Fig. S1B). These results demonstrate that the migra-
tion of lymphocytes into HSEC occurs in situ during
chronic liver disease.
IFNc ACTIVATION OF LIVER
SINUSOIDAL ENDOTHELIAL
CELLS PROMOTES
INTRACELLULAR MIGRATION OF
LYMPHOCYTES
Having visualized the presence of lymphocytes with-
in HSEC in human tissue we proceeded to study
migration of lymphocytes across endothelial mono-
layers in ﬂow based adhesion assays to study the
HEPATOLOGY, Vol. 00, No. 00, 2016 PATTEN ET AL.
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FIG. 1. Lymphocytes migrate into sinusoidal endothelial cells in human chronic liver disease. (A) Immunoﬂuorescent staining of liver
sections from a patient with primary biliary cirrhosis demonstrating the presence of lymphocytes in portal regions within ﬁbrous sep-
tum. (B) Immunoﬂuorescent staining of the same liver demonstrating lymphocytes within the sinusoidal channels. CD31 lymphocytes
appear in red and stabilin-1–positive hepatic sinusoidal endothelium appears in green. (C) Lymphocytes (red) within the sinusoidal
channels with one lymphocyte within the sinusoidal lumen and another within the endothelial cell (green). Arrows indicate the intra-
endothelial lymphocyte. (D) Two-dimensional image of orthogonal (XZ) projection of a CD31 lymphocyte (red) colocalizing with a
stabilin-1–positive (green) endothelial cell. (E,F) Three-dimensional reconstruction of the orthogonal (XZ) projection in panel D with
CD31 red signal only (E) and overlay of stabilin-1–positive green signal (F). Scale bars 5 20 lm (A,B), 10 lm (C), and 5 lm (D).
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molecular basis of lymphocyte recruitment under levels
of physiological shear stress.(14) In these assays HSEC
require preactivation with cytokine to promote adhe-
sion of lymphocytes. TNFa and IFNc are known to be
signiﬁcantly up-regulated in inﬂammatory liver disease
and important activators of endothelium during cellu-
lar injury.(11,17)
More recently, we have incorporated a “ﬁxed cell”
technique, where monolayers of HSECs were perfused
with lymphocytes under shear stress underwent ﬁxa-
tion and were stained with cellular dyes and speciﬁc
antibodies, followed by analysis with confocal micros-
copy to study the route taken by lymphocytes during
transendothelial migration across HSECs. Using this
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FIG. 2. Intracellular migration of lymphocytes into primary HSECs. (A) Representative confocal images of lymphocytes adherent to
cytokine-treated HSEC monolayer. HSEC cytoplasm was stained with CellTracker CMFDA (green), lymphocyte membrane was
stained with CD4 marker (red), and HSEC and lymphocyte nuclei were stained with DAPI (blue). (B) Immunoﬂuorescent staining
for lysosomal markers VAMP-7 (red) and (C) CD63 (red) were performed. Orthogonal (XZ) projections are shown corresponding to
the plane of the red line in the overlay images. Arrows in the orthogonal projections indicate the HSEC/lymphocyte nucleus and its
relationship to the lysosomal compartment. (D) Quantiﬁcation of intracellular migration. (E) Adhesion of peripheral blood lympho-
cytes on cytokine-treated HSECs. (F) Quantiﬁcation of intracellular migration on TNFa- and IFNc-treated HSECs at various time
points. Quantitative data are the mean 6 SEM of three independent experiments. Statistical signiﬁcance was determined using one-
way analysis of variance, with a Tukey’s post hoc multiple comparison test. *P < 0.05. Scale bars 5 20 lm (A), 10 lm (B,C), and
5 lm (A-C, orthogonal projections).
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technique, incorporating cytoplasmic dyes and mem-
brane markers such as CD4 to distinguish between
HSECs and lymphocytes, we observed lymphocytes
migrating directly into HSECs by way of the transcel-
lular route (Fig. 2A). To conﬁrm that migrating lym-
phocytes were within endothelial cell bodies, we
stained intracellular structures focusing on the lyso-
somal compartment which is highly enriched in
HSECs. By staining lysosomes with VAMP-7 and
CD63 we demonstrated that lymphocytes displace the
lysosomal compartment during intracellular migration
(Fig. 2B,C).
We then quantiﬁed this route of migration by
counting the proportion of total adherent cells cap-
tured migrating into HSECs at a speciﬁc time point.
Very few lymphocytes were detected within HSECs
after TNFa stimulation, but a signiﬁcant number of
cells were seen to use this route following the addition
of IFNc (Fig. 2D). Treatment of HSECs with other
interferon family cytokines or lipopolysaccharide did
not promote intracellular migration (Fig. 2D) despite
leading to an increase in the number of adherent lym-
phocytes per ﬁeld of similar magnitude to that seen
with IFNc (Fig. 2E). These experiments were per-
formed after 24 hours of stimulation. To assess wheth-
er duration of IFNc stimulation impacted on this
migration experiments were done at various time
points (2, 4, and 24 hours). We found that 24-hour
stimulation of IFNc was required before signiﬁcant
numbers of lymphocytes underwent intracellular
migration (Fig. 2F). To differentiate this process from
phagocytosis, we performed our ﬂow assays with non-
viable (ﬁxed) lymphocytes. We did not visualize any
internalization of nonviable lymphocytes by HSECs,
repeat experiments with viable lymphocytes demon-
strated clear displacement of the HSEC cytoplasm
(Fig. 3A,B). To determine whether this was a speciﬁc
feature of HSECs, we tested the ability of IFNc to
promote this route of migration in vascular endothelial
cells isolated from HUVECs. We found that whereas
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FIG. 3. Nonviable lymphocytes are not internalized by HSECs. (A) Representative confocal images of nonviable (ﬁxed) lymphocytes
perfused over TNFa- and IFNc-treated HSECs in a ﬂow adhesion assay. Endothelial cells were stained with CellTracker CFMDA
(green) and nuclei were stained with DAPI (blue). (B) Repeat experiments with viable lymphocytes. Arrows indicate intracellular lym-
phocytes. Images are representative of three independent experiments. Scale bar 5 30 lm (A,B).
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total adhesion was similar between HSECs and
HUVECs, intracellular migration in HUVECs
occurred signiﬁcantly less frequently compared with
HSECs (Fig. 4A-D). These results demonstrate that
IFNc has a particular effect on lymphocyte migration
across HSECs, which occurs less frequently during
interactions with conventional vascular endothelium.
We assessed the contribution of adhesion molecules
focusing on the receptors intracellular adhesion
molecule-1 (ICAM-1) and stabilin-1, both of which
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FIG. 4. IFNc promotes intracellular migration of lymphocytes into HSECs but not HUVECs. (A,B) Representative confocal images
of lymphocytes adherent to TNFa- and IFNc-treated HSEC and HUVEC monolayers in a ﬂow adhesion assay. Endothelial cells
were stained with CellTracker CFMDA (green) and nuclei were stained with DAPI (blue). Arrows indicate intracellular lymphocytes.
(C) Quantiﬁcation of adhesion and (D) intracellular migration of lymphocytes into HSEC and HUVEC monolayers in a ﬂow adhe-
sion assay. Quantitative data are the mean 6 SEM of ﬁve independent experiments. Statistical signiﬁcance was determined using a
two-tailed t test. *P < 0.05. Scale bars 5 25 lm (A,B).
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FIG. 5. Intracellular migration is dependent on ICAM-1 but not inhibited by disruption of junctional complexes. (A) Quantiﬁcation
of intracellular migration of lymphocytes across HSECs pretreated with blocking antibodies to ICAM-1, CLEVER-1/stabilin-1
(STAB-1), and PDL1. Results are the mean 6 SEM of at least three independent experiments. (B) Quantiﬁcation of intracellular
migration of lymphocytes pretreated with CXCR3 blocking antibody or IMC across HSECs. Results are the mean 6 SEM of at least
three independent experiments. (C) Quantiﬁcation of intracellular migration of lymphocytes across HSECs pretreated with control
media or media supplemented with Blebbistatin (Blebb) or cytochalasin D (Cyto D). Results are the mean 6 SEM of three indepen-
dent experiments. (D) Measurement of transelectrical endothelial resistance across untreated or cytokine-treated HSECs and
HUVECs. Results are the mean 6 SEM of six independent experiments. (E) Representative images of cell tracker CFMDA-labeled
endothelial monolayers (green) after ﬂow assay pretreated with TNFa and IFNc and cultured in ﬂow media or calcium-free ﬂow
media. Arrows indicate lymphocyte intracellular migration. (F) Quantiﬁcation of intracellular migration of lymphocytes across
cytokine-treated HSEC and HUVEC monolayers cultured in ﬂow media (Media) or calcium-free ﬂow media. Results are the mean
6 SEM of three independent experiments. Statistical signiﬁcance was determined using a two-tailed t test (A-C) and one-way analy-
sis of variance with a Tukey’s post hoc multiple comparison test (D,F). Scale bar 5 25 lm (E). *P < 0.05. **P < 0.005. ****P <
0.0005.
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are involved in diapedesis of lymphocytes across
HSECs,(12) and programmed death ligand-1 (PDL1),
which is up-regulated by IFNc and contributes to leu-
kocyte recruitment.(18,19) We found that blocking of
ICAM-1 or CLEVER-1/stabilin-1 led to a signiﬁcant
reduction of lymphocyte intracellular migration into
HSECs and that blocking PDL1 had a small but sig-
niﬁcant effect (Fig. 5A). To study the role of
interferon-inducible chemokines (CXCL9-11), we
inhibited their receptor, CXCR3. Blocking CXCR3 in
lymphocytes did not affect their ability to migrate into
HSECs (Fig. 5B). Additionally, we measured tran-
scription levels of CXCL9-11 in IFNc-treated
HUVECs compared with HSECs and observed sig-
niﬁcantly lower levels in HSECs compared with
HUVECs (Supporting Fig. S2A). We proceeded to
assess whether interferon-inducible factors could have
an indirect effect on the adhesion molecules that medi-
ate intracellular migration, particularly ICAM-1 and
CLEVER-1/stabilin-1. Transcription levels of
ICAM-1 were signiﬁcantly up-regulated with TNFa,
but IFNc did not have an additive effect (Supporting
Fig. S2B). Levels of CLEVER-1/stabilin-1 demon-
strated a nonsigniﬁcant decreased trend in transcrip-
tion with cytokine stimulation (Supporting Fig. S2C).
Intracellular migration is likely to require changes or
reorganization in the cytoskeleton to allow migration
within the endothelial cell. We initially assessed how
cytokine stimulation affected key components of the
cytoskeleton within HSECs. Imaging and quantiﬁca-
tion of actin and microtubule ﬁbers demonstrated a
signiﬁcant reduction and reorganization of the cyto-
skeleton with TNFa (Supporting Fig. S3A,C,E,F).
Further reduction of actin ﬁbers was noted with the
addition of IFNc (Supporting Fig. S3E). We went on
to study these cytoskeleton components during lym-
phocyte interaction with HSECs under shear stress.
We did not detect lymphocytes interacting with endo-
thelial actin during intracellular migration (Supporting
Fig. S3B), but endothelial microtubule structures were
enriched around lymphocytes, especially near endothe-
lial junctions (Supporting Fig. S3D). We then studied
the functional contribution of actin and microtubule
formation to intracellular migration using cytochalasin
D and Blebbistatin to inhibit actin polymerization and
myosin II, respectively. Whereas pretreatment of
endothelial cells with cytochalasin D had no impact,
pretreatment with Blebbistatin signiﬁcantly reduced
intracellular migration (Fig. 5C). Collectively, these
results demonstrate that lymphocyte migration into
HSECs is mediated by a combination of typical and
atypical adhesion molecules facilitated by cytoskeletal
changes affecting predominantly the microtubule
compartment.
To determine whether alterations in endothelial per-
meability explain the difference between HSECs and
HUVECs, we used transendothelial electrical resis-
tance to compare the permeability of HSEC and
HUVEC monolayers. Although HSECs demonstrat-
ed a lower electrical resistance compared with
HUVECs in the resting state, both endothelial types
had similar permeability quantiﬁed by electrical resis-
tance in response to IFNc and TNFa stimulation (Fig.
5D). In addition, permeability measured using a ﬂuo-
rescein isothiocyanate–dextran assay was comparable
between HUVECs and HSECs (Supporting Fig.
S4A).
Changes in endothelial junctions are likely to be
required for cell-to-cell migration, which led us to
study endothelial junctional integrity in this process.
We disrupted junctional complexes by preculturing the
endothelial monolayers in calcium-free media,(20) but
this had no effect on total number of lymphocytes
adhering to the endothelial surface (Supporting Fig.
S4B) or on the number of cells undergoing intracellular
migration into HSECs (Fig. 5E,F). Our ﬁndings
demonstrate that lack of junctional integrity does not
prevent lymphocyte intracellular migration and that
this migratory pathway appears to be independent of
endothelial permeability.
REAL-TIME IMAGING UNDER
CONDITIONS OF FLOW
DEMONSTRATES A NOVEL STEP
OF INTRACELLULAR
LYMPHOCYTE CRAWLING
To study lymphocyte migration in real time, we
developed a confocal microscopy technique to visualize
lymphocyte/endothelial interactions under conditions
of physiological shear. Time-lapse recordings allowed
the analysis of lymphocyte migration across HSECs in
a selected ﬁeld of view. These recordings conﬁrmed
our earlier ﬁndings with the ﬁxed cell technique that
treatment with TNFa led to minimal disruption of the
endothelial cytoplasm during lymphocyte migration
(Supporting Movies S1 and S2). In contrast, treatment
with a combination of TNFa and IFNc promoted
intracellular migration of lymphocytes into HSECs
and led to clear disruption of the cytoplasm (Support-
ing Movies S3 and S4).
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Thus far, our imaging of intracellular lymphocytes
was on ﬁxed samples; we then conﬁrmed that we could
visualize intracellular lymphocytes in live cells using z-
stack imaging in real time. The imaging conﬁrmed
lymphocytes within endothelial cells and we were able
to clearly distinguish them from lymphocytes adherent
to the endothelial surface (Fig. 6A). Although confocal
microscopy demonstrated lymphocytes within liver
endothelial cells, it could not deﬁne the ultrastructural
changes involved in this process, leading us to under-
take transmission electron microscopy of monolayers
of HSECs treated with TNFa and IFNc. Endothelial
cells respond to cytokine activation by an increase in
biosynthetic organelles,(21) and this was evident in the
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HSEC ultrastructure visualized by transmission elec-
tron microscopy (Supporting Fig. S4C,D). When
cytokine-treated HSECs were incubated with lympho-
cytes, we successfully identiﬁed lymphocytes within
endothelial structures, which were distinguishable
from other endothelial organelles (Fig. 6B). A clear
“double” membrane was visible around the lympho-
cytes (Fig. 6B), suggesting that intracellular migration
of lymphocytes into HSECs is facilitated by the forma-
tion of intracellular vesicles.
Real-time imaging with confocal microscopy
highlighted a migratory pattern that could not be visu-
alized using phase contrast microscopy or our ﬁxed cell
technique. Analysis of time-lapse recordings demon-
strated that a proportion of lymphocytes were migrat-
ing intracellularly and then crawling from the
cytoplasm of one endothelial cell to another before
completing transendothelial migration (Supporting
Movie S5 and Fig. 6C,D). Three-dimensional recon-
struction of the z-stack images demonstrated lympho-
cytes within the endothelial cytoplasmic compartment
in contrast to those crawling on the surface (Support-
ing Fig. S5). To our knowledge, lymphocyte crawling
from one endothelial cell to another intracellularly has
never been described. A lymphocyte that crawls intra-
cellularly between cells has to cross junctional barriers.
To study this process, we returned to our ﬁxed cell
technique and used VE-cadherin and CD31 as endo-
thelial junctional markers. We were able to demon-
strate lymphocytes migrating from cell to cell and
crossing cell junctions; the VE-cadherin complexes
were clearly disrupted as lymphocytes migrated across
the junction (Fig. 6E). In contrast, CD31 could be
seen enriching the junctional pore as the lymphocyte
migrated from one endothelial cell to the next (Fig.
6F). This appeared similar to ﬁndings described by
previous groups demonstrating how CD31 is targeted
to segments of the membrane during leukocyte–endo-
thelial interactions.(22)
The ﬂow adhesion assay performed in a microslide
with a monolayer of endothelial cells does not incorpo-
rate a chemokine gradient or a substantial subendothe-
lial compartment, and these features might inhibit
transendothelial migration and promote intracellular
crawling. To model this, we performed lymphocyte
migration assays on a layer of HSECs that was
mounted on a collagen plug containing the chemokine
CXCL10 to provide a gradient and a subendothelial
compartment, which would recapitulate the situation
in vivo during lymphocyte recruitment. We found that
despite the presence of the gradient and a subendothe-
lial space, we still detected intracellular lymphocytes
and also identiﬁed lymphocytes crossing HSEC junc-
tions (Supporting Fig. S5B,C). Collectively, these
results demonstrate a new step in the adhesion cascade
wherein lymphocytes crawl intracellularly between
endothelial cells.
HUMAN LIVER SINUSOIDAL
ENDOTHELIAL JUNCTIONAL
MOLECULAR EXPRESSION
DIFFERS FROM HUVECs
Our identiﬁcation of intracellular cell-to-cell crawl-
ing associated with junctional disruption led us to
compare in more detail the junctional complexes in
HUVECs and HSECs. We obtained normal primary
human HSECs from the margins of liver tissue
resected to remove colorectal metastases and from
unused donor organs. HSEC were also obtained from
explanted liver tissue from patients with chronic liver
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FIG. 6. Intracellular crawling of lymphocytes across HSEC monolayers. (A) Live cell imaging of peripheral blood lymphocytes
migrating across TNFa- and IFNc-treated HSECs under shear stress. HSECs were stained with CellTracker CFMDA (green), lym-
phocytes with cell tracker BMQC (blue), and HSEC junctions with CellMask orange plasma membrane stain (red). Orthogonal (XZ)
projection is shown corresponding to the plane of the red line. (B) Left: Representative transmission electron microscopy image of an
intracellular lymphocyte within TNFa- and IFNc-treated HSECs. Right: Arrows in high magniﬁcation images of two regions within
the intracellular lymphocyte indicate a double membrane. (C) Still images of Supporting Movie S5 taken at 1-minute intervals of
time-lapse recordings of lymphocytes migrating across TNFa- and IFNc-stimulated HSEC monolayer under shear stress. HSEC
cytoplasm was prelabeled with CellTracker CFMDA (green) and lymphocytes were prelabeled with CellTracker BMQC (red). (D)
The same sequence of images shown in panel C with the red (lymphocyte) signal omitted. The arrows indicate lymphocytes (red)
undergoing intracellular crawling from one endothelial cell to the adjacent cell displacing the cytoplasm of the endothelial cell (green).
Note the redistribution of endothelial cytoplasm in panel D as the lymphocytes migrate from cell to cell. (E) Representative confocal
images of lymphocyte cell-to-cell crawling across TNFa- and IFNc-treated HSEC monolayer. HSEC cytoplasm was stained with
CellTracker CFMDA (green) and HSECs and lymphocyte nuclei were stained with DAPI (blue) and VE-cadherin (red). Arrows
indicate disruption of VE-cadherin at the endothelial junction as lymphocytes migrate to the adjacent HSECs. (F) Representative con-
focal images of experiment with same conditions as panel D with staining of CD31 (red). Arrows indicate enrichment of CD31 at
the junction as lymphocyte migrates to the adjacent HSECs. Scale bars 5 25 lm (A,C,D), 10 lm (A, orthogonal projection, E,F), 2
lm (B, left), and 1 lm (B, right).
HEPATOLOGY, Vol. 00, No. 00, 2016 PATTEN ET AL.
11
disease. As we have shown previously,(12) isolated
HSECs express CD31 and the scavenger receptor
stabilin-1 (Fig. 7A). The junctional molecules identi-
ﬁed in HSECs included VE-cadherin, junctional
adhesion molecule-A (JAM-A), and zona occludens-1
(ZO-1) (Fig. 7B-D). Occludin, claudin-1, and E cad-
herin were not detected. We next compared quantita-
tive expression of junctional molecules in HSECs
isolated from normal liver tissue, or tissue from
patients with parenchymal liver disease (alcoholic liver
disease and nonalcoholic fatty liver disease) or biliary
disease (primary biliary cirrhosis, primary sclerosing
cholangitis). We found that the proﬁle and quantiﬁca-
tion of junctional molecular expression was very similar
between the disease groups (Fig. 7E). We next
assessed the effect of cytokine stimulation on junction-
al molecule expression. A combination of TNFa and
IFNc stimulation led to a small but nonsigniﬁcant
reduction in junctional molecule expression (Support-
ing Fig. S6A). Finally, we made a direct comparison of
junctional molecule expression between HSECs and
HUVECs (Fig. 7F). We found quantitatively higher
expression of JAM-A in HUVECs compared with
HSECs and occludin, an integral plasma membrane
protein located at tight junctions, was found in
HUVECs but was absent from HSECs. These studies
conﬁrm that the junctional molecule expression
between HSECs from diseased and normal livers are
similar in composition but are signiﬁcantly different
from HUVECs a prototypic venular endothelial cell.
MICROARRAY ANALYSIS OF
HSECs AND HUVECs CONFIRMS
SIGNIFICANT TRANSCIPTOME
DIFFERENCES IN MOLECULES
INVOLVED IN JUNCTIONAL
COMPLEX FORMATION AND
REGULATION OF CELLULAR
CYTOSKELETON
To further explore the potential mechanisms medi-
ating intracellular crawling, we compared gene expres-
sion between HSECs and HUVECs using microarray
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FIG. 7. Junctional molecular expression differs between HSECs and HUVECs. (A-D) Immunoﬂuorescent staining of primary
HSECs for CLEVER-1/stabilin-1 (green) and junctional molecules (red). Images representative of three separate HSEC isolates. (E)
Cell-based ELISA of junctional molecule expression in HSECs isolated from normal livers and chronically inﬂamed livers. (F) Cell-
based ELISA of junctional molecule expression in HSECs compared with HUVECs. Data are the mean of three experiments and
values represent the mean optical density at 490 nm of three replicate wells minus the optical density of an isotype-matched control
antibody. Statistical signiﬁcance was determined by two-tailed t test. **P < 0.005. Scale bars 5 20 lm (A-D).
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FIG. 8. Microarray demonstrates differential gene expression changes between HSECs and HUVECs in response to TNFa and IFNc
challenge. (A) Heat map images of gene expression changes. Unstimulated HSECs and HUVECs were compared with HSECs and
HUVECs that had been stimulated with TNFa and IFNc (10 ng/mL) for 24 hours. (B) Summary of the total number of mutual and
exclusively up-regulated and down-regulated genes after cytokine stimulation in HSECs and HUVECs. Genes were identiﬁed to be up-
regulated or down-regulated based on log ratios that were 2-fold or greater. (C) Comparative messenger RNA expression between
HUVECs and HSECs of occludin, CD36, macrophage mannose receptor (MRC-1), and podoplanin (PDPN). (D,E) Pathway analysis
of up-regulated and down-regulated genes in unstimulated HSECs compared with HUVECs. (F) Pathway analysis of down-regulated
genes in stimulated HUVECs compared with stimulated HSECs. The pathways are plotted against their corresponding 2log10 values
of probability on the x axis. Statistical signiﬁcance was determined using a two-tailed t test. ***P < 0.001. ****P < 0.0005.
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analysis. Cytokine stimulation resulted in more genes
being up-regulated in HUVECs than in HSECs (Fig.
8A). Whereas over 1000 genes were up-regulated in
HUVECs, fewer genes were up-regulated in HSECs
in response to TNFa and IFNc, and 31 were exclusive
to HSECs (Fig. 8B). Pathway analysis did not identify
an enriched pathway within this group of up-regulated
genes.
We then compared the transcription proﬁle of
unstimulated HSECs and HUVECs and found 1164
genes signiﬁcantly up-regulated in HSECs compared
with HUVECs and 1346 genes up-regulated in
HUVECs compared with HSECs. We validated the
microarray ﬁndings by conﬁrming differences in mes-
senger RNA between HSECs and HUVECs by way
of quantitative polymerase chain reaction for four genes
differentially expressed in the microarray: occludin,
CD36, macrophage mannose receptor, and podoplanin
(Fig. 8C). Down-regulation of occludin at the tran-
script level further supported our earlier junctional pro-
tein comparison of HSECs with HUVECs (Fig. 7F).
Pathway analysis demonstrated that the majority of
processes up-regulated in HSECs were related to
metabolism including lipids, fatty acids, carboxylic
acid, ketones, and oxoacid metabolic processes (Fig.
8D and Supporting Table 1). A total of 175 pathways
were found to be signiﬁcantly up-regulated in
HUVECs and included cell junction assembly, cell
junction organization, and adherens junction organiza-
tion (Fig. 8E and Supporting Table 2). A total of 1630
genes were exclusively down-regulated in HUVECs
after cytokine stimulation, and a pathway enrichment
analysis of this group of genes (Supporting Table 3)
revealed that several of these pathways were related to
the cellular cytoskeleton, especially the microtubule
compartment, including regulation of microtubule
cytoskeleton organization, microtubule anchoring,
microtubule polymerization, and microtubule organi-
zation (Fig. 8F). Collectively, these results support our
ﬁndings that HUVECs and HSECs are characterized
by signiﬁcant differences in junctional formation.
Discussion
The endothelium plays an active role in directing
and selecting leukocyte subset recruitment to tissues
from blood.(23) A key step in this process is diapedesis,
and the conventional pathway is the paracellular route
where a leukocyte migrates between endothelial cells at
cellular junctions.(24) Although a transcellular route
was described more than 40 years ago, it was only
recently conﬁrmed that leukocytes could migrate by
this second route,(25) and the reasons why leukocytes
take a paracellular rather than a transcellular route are
poorly understood.(26) Endothelial heterogeneity is
likely to contribute, because previous studies have
demonstrated that transcellular migration occurs at a
much higher frequency in endothelium lining micro-
vascular beds,(25) including our own work in
HSECs.(12) We now extend these ﬁndings to demon-
strate a new migratory pattern of intracellular crawling
of lymphocytes through the body of liver sinusoidal
endothelial cells to adjacent endothelial cells, which is
promoted by IFNc treatment of endothelial cells. We
have shown this using real-time imaging of liver cells
under conditions of physiological ﬂow. Confocal
microscopy and ultrastructural studies demonstrate
that lymphocytes within endothelial cells are sur-
rounded by a double membrane and displace endothe-
lial organelles as they migrate. These intracellular
lymphocytes migrate to other liver endothelial cells by
disrupting the VE-cadherin network, which is also
implicated in paracellular leukocyte migration.(27) This
form of migration also involves the enrichment of
CD31 at intercellular junctions and the contribution of
the microtubule cytoskeleton. Changes in the endothe-
lial cytoskeleton are presumably required to allow the
lymphocytes to migrate through the cytoplasm. Migra-
tion via the lateral bordering recycling compartment,
which has been shown to contribute to leukocyte para-
cellular and transcellular migration, is characterized by
mobilization of CD31 and the microtubule network
and our data suggest this compartment also regulates
intracellular crawling.(28) Our ﬁndings that intracellu-
lar crawling still occurred despite the blockade of
CXCR3 suggests that this process is independent of
the previously described pathway of lymphocyte migra-
tion mediated by intracellular chemokine stores,(29) but
we cannot rule out other indirect effects of interferon
inducible factors on this step in migration. Our experi-
ments demonstrated that IFNc did not signiﬁcantly
increase the transcription of ICAM-1 or CLEVER-1/
stabilin-1, but we have previously shown that TNFa
and IFNc stimulation of HSECs can promote cell sur-
face expression of CLEVER-1/stabilin-1.(12) The
effects of IFNc on this step of migration required 24-
hour stimulation and were not seen with shorter times.
Cytokine stimulation of endothelium can be character-
ized as type I or type II activation(30) where type II
activation occurs with longer periods of stimulation
characterized by increased gene transcription and de
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novo protein synthesis, characterized by hypertrophy of
the endothelial cell and increased biosynthetic organ-
elle formation.(31) Our ﬁndings suggest that type II
activation is required for intracellular crawling.
The phenomenon was seen far less frequently in
HUVECs, suggesting that the unique phenotype of
HSECs, particularly differences in junctional complexes,
plays a major role in this phenomenon. Liver sinusoidal
endothelial cells have distinct molecular complexes at
their junctions compared with vascular endothelium,
showing much lower levels of VE-cadherin, JAM-A,
ZO-1, CD31, and absent occludin.(32) These differences
were maintained in HSECs isolated from patients with
chronic inﬂammatory diseases. Conventional endothelial
tight junctions are likely to be required for “directed” leu-
kocyte migration through the paracellular route. This is
supported by recent ﬁndings with a blood–brain barrier
model characterized by robust tight junctions where
>98% of transendothelial migration was paracellular.(33)
Additionally, our study shows that if membranes are dis-
rupted by calcium-free media, intracellular migration is
increased. Thus, the relative lack of tight junction mole-
cules in sinusoidal endothelium may actively promote
both transcellular migration and intracellular crawling
between endothelial cells.
Why should intracellular lymphocyte migration be a
characteristic of hepatic sinusoidal endothelium? One
explanation may be the important role played by sinu-
soidal endothelium in the liver in removing particulates
and other factors that constantly enter the liver from
the gut via the portal vein. Hepatic sinusoidal endothe-
lium expresses a large number of scavenger receptors
that are not found on vascular endothelium and has
the capability to remove, internalize, and process or
degrade a range of antigens. It also plays an important
role in determining the nature of the adaptive immune
response to such antigens by inducing antigen-speciﬁc
tolerance in T lymphocytes. It is thus possible that the
intracellular migration we have observed contributes to
this function by allowing lymphocytes to perform
immune surveillance for intracellular pathogens.
Our ﬁndings may also demonstrate a key step in the
lymphocyte migratory route through the liver. Lym-
phocytes continually recirculate through the liver under
steady-state conditions. Although hepatic sinusoids
have been established as the major site of leukocyte
recruitment, the migratory route taken by lymphocytes
through the liver is poorly understood. Different zones
within the hepatic acinus are associated with different
hepatocyte functions deﬁned by differential expression
of, for instance, cytochrome P450 enzymes.
Lymphocytes may thus need to be directed to particular
compartments within the hepatic parenchyma to pro-
vide efﬁcient detection and clearance of pathogens or
harmful antigens. Furthermore, most forms of hepatitis
are associated with a portal inﬁltrate even when the pre-
sumed antigen is conﬁned to hepatocytes (e.g., viral
hepatitis or autoimmune hepatitis). Kinetic studies in
experimental models have demonstrated that lympho-
cytes migrate from the hepatic sinusoids to the portal
tract and then drain to hepatic lymph nodes.(34) During
chronic inﬂammatory diseases lymphocyte recruitment
increases often leading to portal inﬁltrates.(35) However,
the route taken by lymphocytes from the sinusoids to
the portal tracts is not known. Migration from the
hepatic sinusoids to the portal tract may occur via the
space of Disse, the subendothelial layer containing the
hepatic pericyte or stellate cell, and this appears to be
the route taken by activated dendritic cells to exit the
liver parenchyma and enter portal tracts. Our ﬁndings
suggest that lymphocytes may also crawl intracellularly
from endothelial cell to endothelial cell toward the por-
tal regions. This route may become more relevant dur-
ing chronic disease when collagen accumulates in the
space of Disse, which may make it difﬁcult for lympho-
cytes to use this pathway to portal tracts. The fact that
we saw a marked increase in intravascular crawling in
HSECs treated with a combination of TNFa and IFNc
supports a particular role in inﬂammation. We therefore
believe this novel ﬁnding provides a new insight into
lymphocyte migration and could lead to new treatments
for inﬂammatory liver diseases.
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